Company Overview and News

 
Shares rise as Tourism Holdings upgraded

18h nzherald.co.nz
New Zealand shares edged higher as Tourism Holdings snapped a seven-day slide on a broker upgrade. Spark New Zealand was among several companies shedding rights to dividends.
CEN BGR FBU AIR FCREY SPKKY NZTCY SPK NZTCF FRCEF ANZFY COENY AIZ COENF GNE FBU THL ANZLY CEN ANZFF GNE MEZ GEL

 
Former Prime Minister Dame Jenny Shipley accused of reckless trading as Mainzeal director

2018-09-17 nzherald.co.nz
Former Prime Minister Jenny Shipley and husband Burton were in court for the opening day of the high-profile case against Mainzeal's former directors.
CICHY GNE GNE CICHF CCB GEL 0939

 
Power generators banked $5.4 billion in extra profits in 2010-16 - report

2018-09-14 nzherald.co.nz
New Zealand power generators pocketed an extra $5.4 billion on profits from 2010 to 2016 over and above what they would have if the wholesale electricity market was truly competitive, according to a report by a University of Auckland economist.
GNE GNE MEZ GEL

 
Trade Me leads NZ shares gain

2018-09-13 nzherald.co.nz
New Zealand shares rose, joining a regional rally on optimism over US-China trade relations. Fonterra Cooperative Group's first annual loss dominated local headlines.
CEN AIR FCREY NZTCF ACKDF ANZFY AUKNY AIZ KMD COENF GNE CEN KMD GEL SML KTHDY AIA FBU SPKKY NZTCY SPK FRCEF COENY AIA FBU ANZLY ANZFF GNE MEZ

6
Oil & Gas Refining & Marketing MLP Outlook: Slide to Continue

2018-09-12 zacks
Master limited partnerships (or MLPs) differ from regular stocks in that interests in them are referred to as units and unitholders (not shareholders) are partners in the business. Importantly, these hybrid entities bring together the tax benefits of a limited partnership with the liquidity of publicly traded securities. The assets that these partnerships own typically are oil and natural gas pipelines and storage facilities.
GNE CAPL GNE TRGP GEL

 
NZ shares jump 2 per cent as energy stocks rally

2018-09-11 nzherald.co.nz
New Zealand shares rose strongly in busy trading, led by A2 Milk Co and Contact Energy. Energy stocks gained on the release of a sector report which allayed fears of tighter regulation.
CEN COENF GNE CEN GNE COENY MEZ GEL

 
Barbara Chapman, Belinda Moffat, John Sproat appointed to Reserve Bank Act review panel

2018-09-07 nzherald.co.nz
The government has made three new appointments to the panel reviewing the Reserve Bank Act, as the "wide-ranging" review enters its second phase.
GNE FBU FBU FCREY GNE FRCEF GEL

12
Top Analyst Upgrades and Downgrades: Apple, AT&T, BBVA, Cisco, Dollar Tree, Facebook, Roku, Seagate, Turkcell, Verizon and More

2018-09-04 247wallst
Stocks were indicated lower on Tuesday after the three-day weekend, but the major market equity indexes may have recently hit all-time highs after a strong earnings season. Investors have seen less upside from the “buy the dips” trends that had worked for several years. Those same investors also are trying to decide how they want their investments positioned for the rest of 2018.
BBVA FB CTSH DLTR ANET EVR ES T AAPL ADI CSCO TRI MS GEL

13
Midstream Out Of Office Washout

2018-09-02 seekingalpha
Midstream had a rough week, the worst since late March and 4th worst so far this year. Oil prices rallied for a second straight week, NGL prices were sharply higher, the broad stock market was higher again, but midstream and MLPs lagged badly.
NGL CCR TGE ENB CEQP GNE EQM KMI TRP WMB AMGP OKE ED KMR CVB GEL NEE TRP VLP RGCO ENB ETP GNE TRGP PBA KMRFZ

 
GEL / Genesis Energy, L.P. FORM 8-K (Current Report)

2018-08-31 sec.gov
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
GEL

 
Genesis Energy (GEL) to Divest Midstream Assets for $300M

2018-08-30 zacks
Genesis Energy, L.P. (GEL - Free Report) recently announced that it has agreed to divest its Powder River Basin Midstream properties for around $300 million in net cash proceeds, which will be used to pay down its credit revolver’s outstanding balance. Genesis is selling the assets to a subsidiary of Dallas-based Silver Creek Midstream, LLC, which is exercising its option to buy the properties.
HLX GNE MDR GNE GEL MCDFF

 
Alleghany Subsidiary Buys Renewal Rights From Maiden Re

2018-08-30 zacks
TransRe, a wholly owned subsidiary of Alleghany Corporation (Y - Free Report) , announced that it has purchased exclusive renewal rights of Maiden Holdings, Ltd.’s (MHLD - Free Report) U.S. treaty reinsurance underwriting business. Also, the U.S. treaty team of Maiden Re will join TransRe. Subsequently, TransRe will offer renewal quotations for this operation, which focuses on regional property and casualty, accident and health plus personal auto insurers.
GNE MHLA MHLD PGR GNE NAVG Y GEL

2
Dean Foods Dips to a 52-Week Low, Input Costs a Key Concern

2018-08-30 zacks
Shares of Dean Foods Company (DF - Free Report) reached a 52-week low of $7.42 before closing the session a tad higher at $7.57 on Aug 29. The company has long been battling against hurdles related to input cost inflation, soft volumes in U.S. fluid milk and increased retailer investments in the private label space, which is weighing on its performance. In fact, such concerns affected the company’s second-quarter 2018 results and also compelled management to slash its 2018 earnings view.
GNE MED GNE PF GEL CHEF

 
PMN.TO: Second Quarter 2018 Results

2018-08-30 zacks
By John Vandermosten, CFA ProMIS Neurosciences Inc. (TSE:PMN.TO) (OTC:ARFXF) had an encouraging year to date in 2018 over a backdrop of poor results from competitors. In January, the company found that PMN310 did not bind to amyloid beta (Aβ) plaque, thus avoiding the dose limiting ARIA-E that has plagued other less selective Aβ biologics. In March, research in an animal model found that PMN310 was able to cross the blood brain barrier at an equivalent concentration as aducanumab.
GNE GNE ARFXF GEL

1
Campbell (CPB) Sees Soft Q4 Earnings, Unveils Strategic Plans

2018-08-30 zacks
Campbell Soup Company (CPB - Free Report) posted dismal earnings in fourth-quarter fiscal 2018, while sales grew owing to contributions from buyouts. However, on an organic basis, sales remained soft due to weakness in Americas Simple Meals and Beverages unit. Also, in a separate press release, the company announced various actions to improve its business as part of its strategic portfolio review. The company plans to divest non-key businesses including Campbell International and Campbell Fresh, which generated net sales of nearly $2.
GNE MED GNE PF GEL

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to GEL / Genesis Energy, L.P. on message board site Silicon Investor.

Rigel Pharmaceuticals, Inc. (RIGL) Rigel Pharmaceuticals, Inc. (RIGL) Rigel Pharmaceuticals, Inc. (RIGL) Angel Investoru0027s Network Angel Investoru0027s Network Angel Investoru0027s Network
And The 7th Angel Sounded And The 7th Angel Sounded And The 7th Angel Sounded GelTech GelTech GelTech
angel investing u0026 venture capitalists angel investing u0026 venture capitalists angel investing u0026 venture capitalists S. Gelbard S. Gelbard S. Gelbard
DOC - Digital Angel DOC - Digital Angel DOC - Digital Angel Will the republicans support Chuck Hagel in 2008? Will the republicans support Chuck Hagel in 2008? Will the republicans support Chuck Hagel in 2008?
Magellan Petroleum (MPET) Magellan Petroleum (MPET) Magellan Petroleum (MPET) AGCI - Angelciti Entertainment, Inc. AGCI - Angelciti Entertainment, Inc. AGCI - Angelciti Entertainment, Inc.
CUSIP: 371927104